A Study to Evaluate Potential Myocardial Injury Following Elective Direct Current Cardioversion


About this study

The purpose of this study is to prospectively determine if direct current cardioversion (DCCV) results in myocardial injury as assessed by changes in high sensitivity cardiac troponin T (hs-cTnT) assay.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients who are undergoing elective direct current cardioversion, either externally or via the patient’s internal cardioverter-defibrillator.

Exclusion Criteria: 

  • Patients under age 18.

  • Patients with myocardial infarction, coronary artery bypass grafting or any invasive cardiac procedure in the previous six weeks.

  • Pregnant patients.

  • Patients who cannot provide informed consent because of cognitive dysfunction.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ronstan Lobo, M.B., B.Ch., B.A.O.

Open for enrollment

Contact information:

Ronstan Lobo M.B., B.Ch., B.A.O.



More information


Publications are currently not available

Mayo Clinic Footer